Istraživači su razvili kovalentne inhibitore kaspaze koji selektivno blokiraju piroptozu i sekreciju interleukina (IL) - 1β, proces povezan s upalnim bolestima.
Procjena pristranosti (Sredina): U članku se raspravlja o znanstvenom istraživanju o inhibitorima kaspaze i njihovim potencijalnim terapeutskim primjenama.
Zašto činjenice (95): The article presents a detailed scientific study on the mechanism of pyroptosis suppression using covalent caspase inhibitors. The findings are specific, technical, and consistent with current biological understanding of GSDMD and pyroptosis. While the article is labeled as 'unedited' and acknowledg
Zašto objektivnost (98): The article maintains a highly objective tone throughout, presenting data and hypotheses without overt bias or emotional language. It clearly distinguishes between findings, interpretations, and limitations, avoiding any attempt to frame the research in a particular ideological or commercial light.



